|
- Vasant Narasimhan - Wikipedia
Vasant " Vas " Narasimhan (born August 26, 1976) is an American physician and the chief executive officer of Novartis [1][2][3][4] He succeeded Joseph Jimenez who left Novartis in 2018 [5]
- Vasant Narasimhan | Novartis
Vasant (Vas) Narasimhan, M D , has been Chief Executive Officer (CEO) of Novartis since February 1, 2018
- Vas Narasimhan - Reimagining medicine as CEO of Novartis | LinkedIn
At Novartis, we’re reimagining medicine with innovative science and technology to address some of society’s most intractable and long-standing health issues
- Vasant Narasimhan | CEO of Novartis | Leader in Global Healthcare
Vasant Narasimhan is at the forefront of the pharmaceutical industry as CEO of Novartis His innovation makes an impact on global health
- HIGHLIGHTS: Vasant Narasimhan - CEO of Novartis | Norges Bank . . .
Nicolai Tangen speaks with Vasant 'Vas' Narasimhan, CEO of Novartis, about pioneering pharmaceutical innovation They explore breakthrough cell and gene therapies, AI partnerships with leading tech companies, and how Novartis transformed from a sprawling conglomerate into a streamlined drug discovery company
- Novartis CEO and Key Executive Team - Craft. co
Novartis's Chief Executive Officer is Vasant Narasimhan Other executives include Kees Roks, Chief Audit Officer; Harry Kirsch, Chief Financial Officer and 21 others See the full leadership team at Craft
- TIME100 Health: Vas Narasimhan | TIME
In 2018, he became CEO of Novartis and seized the opportunity to direct the company’s vast resources for transformative change
- Vasant Narasimhan - Indiaspora
Dr Vasant Narasimhan is an American physician currently serving as the CEO of Novartis, a multinational pharmaceutical giant He is known for his focus on innovation and access to medicines, particularly in developing countries
|
|
|